Scholars Central

Search Scholars Central

Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.

Advanced searchHide advanced search

In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:

Years

1–25 of 5,348 articles for Tablets

Then save them, add them to a collection or cite them together.
  1. Article · 13 Oct 2023

    An Open Label, Balanced, Randomized, Two Treatments, Two Sequences, Two Periods, Crossover, Single Dose, Bioequivalence Study of Olmesartan medoxomil/Hydrochlorothiazide 20 mg/12.5 mg Coated Tablets of Abbott and Olmetec plusandreg;andnbsp;(Olmesartan medoxomil/Hydrochlorothiazide) 20 mg/12.5 mg Coated Tablets of Daiichi-Sankyo in Healthy, Adult, Human Subjects Under Fasting Condition

    Journal of Bioequivalence & Bioavailability · Volume 15, Issue 5

    evaluate the bioequivalence between Olmesartan Medoxomil/Hydrochlorothiazide 20 mg/12.5 mg coated tablets of Abbott and Olmetec Plus® (Olmesarten Medoxomil/Hydrochlorothiazide) 20 mg/12.5 mg coated tablets of…

  2. Research article · 5 Oct 2023

    An Open Label, Balanced, Randomized, Two Treatments, Two Sequences, Two Periods, Crossover, Single Dose, Bioequivalence Study of Olmesartan Medoxomil/Hydrochlorothiazide 40 mg/12.5 mg Coated Tablets of Abbott and Olmetec Plus® (Olmesartan Medoxomil/Hydrochlorothiazide) 40 mg/12.5 mg Coated Tablets of Daiichi-Sankyo in Healthy, Adult, Human Subjects Under Fasting Condition

    Journal of Bioequivalence & Bioavailability · Volume 15, Issue 4

    evaluate the bioequivalence between Olmesartan Medoxomil/Hydrochlorothiazide 40 mg/12.5 mg Coated Tablets of Abbott and Olmetec Plus® (Olmesarten Medoxomil/Hydrochlorothiazide) 40 mg/12.5 mg Coated Tablets of Daiichi-…

  3. Research article · 5 Oct 2023

    An Open Label, Balanced, Randomized, Two Treatments, Two Sequences, Two Periods, Crossover, Single Dose, Oral Bioequivalence Study of Femelle 20 (Drospirenone 3 Mg and Ethinyl Estradiol 0.02 Mg) Coated Tablets of Abbott and Yaz® (Drospirenone 3 Mg And Ethinyl Estradiol 0.02 Mg) Coated Tablets of Bayer in Healthy, Adult, Human Female Subjects Under Fasting Condition

    Journal of Bioequivalence & Bioavailability · Volume 15, Issue 4

    bioequivalence between Femelle 20 (Drospirenone 3 mg and ethinyl estradiol 0.02 mg) coated tablets of Abbott versus Yaz® (Drospirenone 3 mg and ethinyl estradiol 0.02 mg) coated tablets of Bayer

  4. Research article · 15 Feb 2023

    An Open Label, Balanced, Randomized, Two Treatments, Two Sequences, Two Periods, Single Dose, Cross Over, Bioequivalence Study of Bosutinib 100 Mg Tablets of Abbott Laboratories Versus Bosulif (Bosutinib) 100 Mg Film Coated Tablets of Pfizer Limited Under Fed Condition in Healthy Subjects

    Journal of Bioequivalence & Bioavailability · Volume 15, Issue 1

    purpose of this study was to evaluate the bioequivalence between Bosutinib 100 mg tablets of Abbott Laboratories versus Bosulif (Bosutinib) 100 mg film coated tablets of Pfizer Limited in healthy

  5. Research article · 31 Jan 2023

    An Open Label, Balanced, Randomized, Two Treatments, Two Sequences, Two Periods, Single Dose, Cross Over, Oral Bioequivalence Study of Vildagliptin 50 Mg Tablets of Abbott Laboratories De Colombia vs. Jalra (Vildagliptin) 50 Mg Tablets of Novartis Pharma Stein Ag, in Healthy, Adult, Human Subjects Under Fasting Condition

    Journal of Bioanalysis & Biomedicine · Volume 15, Issue 1

    purpose of this study was to evaluate the bioequivalence between Vildagliptin 50 mg Tablets of Abbott Laboratories de Colombia vs. JALRA (Vildagliptin) 50 mg Tablets of Novartis Pharma Stein

  6. Research article · 19 Dec 2022

    An Open Label, Balanced, Randomized, Two Treatments, Two Sequences, Four Periods, Fully Replicate, Crossover, Bioequivalence Study of Abiraterone Acetate 250 mg Tablets of Abbott Laboratories De Colombia Versus ZYTIGA® (Abiraterone Acetate) 250 mg Tablets of Janssen Biotech, Inc. Under Fasting Condition in Healthy Subjects

    Journal of Bioequivalence & Bioavailability

    purpose of this study was to evaluate the bioequivalence between Abiraterone acetate 250 mg tablet of Abbott laboratories de Colombia versus marketed Abiraterone acetate 250 mg tablet of Janssen Biotech

  7. Research article · 24 Dec 2019

    DEVELOPMENT AND EVALUATION OF ORAL CHEWABLE TABLETS AND ORODISINTEGRATING TABLETS OF TULSI LEAF POWDER FOR DIABETIC PATIENTS

    International Journal of Chemical and Pharmaceutical Analysis · Volume 7, Issue 1

    present research work was to develop and optimize the chewable as well as Orodisintegrating tablet formulation of Tulsi leaf powder. The phytochemical evaluation of Tulsi powder showed the presence ... carbohydrates…

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels